Equibles does not estimate personal net worth.
Get an email with a short summary when DBV Technologies S.A. publishes a filing, an earnings call transcript or a press release.
Get DBVT alertsThe proxy statement of DBV Technologies S.A. reports total compensation of $820,762 for Pharis Mohideen in fiscal 2024, including a base salary of $567,787. Disclosed compensation is on record for 5 fiscal years. Pharis Mohideen has spoken on 1 earnings call across 1 company, most recently for DBV Technologies S.A. on October 28, 2026. DBV Technologies S.A. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at DBV Technologies S.A. includes Daniel Tassé (CEO and Board Member), Michel de Rosen (Chairman), Virginie Boucinha (CFO and Chief Accounting Officer) and 7 others.
“So, if you recall, comfort toddler recruitment ended in the second quarter. It's a supplemental six-month safety study. So, you can add up the timing for that.”
Source not stated
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | DBV Technologies S.A. (DBVT) | Chief Medical Officer | $567,787 | $820,762 |
| 2023 | DBV Technologies S.A. (DBVT) | Chief Medical Officer | $540,750 | $1,279,518 |
| 2022 | DBV Technologies S.A. (DBVT) | Chief Medical Officer | $515,000 | $1,076,807 |
| 2021 | DBV Technologies S.A. (DBVT) | Chief Medical Officer | $466,796 | $1,196,778 |
| 2020 | DBV Technologies S.A. (DBVT) | Chief Medical Officer | $440,000 | $1,032,851 |
